# Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis

> **NCT05136560** · PHASE1,PHASE2 · RECRUITING · sponsor: **CHA University** · enrollment: 102 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT05136560
- **Lead sponsor:** CHA University
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-01-15
- **Primary completion:** 2025-12-30
- **Final completion:** 2026-02-28
- **Target enrollment:** 102 (ESTIMATED)
- **Last updated:** 2025-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05136560

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05136560, "Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT05136560. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*